-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rupatadine for the treatment of allergic rhinitis and urticaria: a look at the clinical data
Erminia Ridolo, Marcello Montagni, Filippo Fassio, Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia & Giorgio Walter Canonica
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation